Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.

American journal of clinical oncology - 1 Jan 2019

Sutera Philip, Kalash Ronny, Flickinger John, Engh Johnathan, Heron Dwight E

Abstract excerpt

INTRODUCTION: Despite multimodal treatment for high-grade gliomas, prognosis remains grim. Prior Radiation Therapy Oncology Group-Recursive Partitioning Analysis (RTOG-RPA) reports indicate based on pretreatment and treatment-related factors, a subset of patients experience a significantly improved survival. Since the development of the RTOG-RPA, high-grade gliomas have seen the widespread introduction of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Chromosome Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Temozolomide

Source

Identifiers

PMID: 29912004
DOI: 10.1097/COC.0000000000000470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.PMID 29912004Read ↗

Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status.Semantic proximity Read ↗

Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.Semantic proximity Read ↗

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors.Semantic proximity Read ↗

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survivalSemantic proximity Read ↗

Real-World Survival Outcomes After (Chemo)radiotherapy for WHO 2021-Classified Gliomas: A Multicenter Analysis of Clinical, Treatment-Related, Dosimetric, and Hematologic Prognostic FactorsSemantic proximity Read ↗

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.Semantic proximity Read ↗

Molecular Subtypes of Anaplastic Gliomas Identified with Somatic-Mutation and Pathway Based Gene SignatureSemantic proximity Read ↗

Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients.Semantic proximity Read ↗

A model of molecular characteristics to classify patients with WHO Grade III gliomasSemantic proximity Read ↗

Clinical Characteristics, Treatment Outcomes, And Genetic Alterations of Radiation-Induced GliomasSemantic proximity Read ↗

Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelinesSemantic proximity Read ↗

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.